Shares of Catalyst Pharmaceuticals fell 4.18% to $3.44 at 15:10 EST on Monday, following yesterday’s downward trend. The Nasdaq Stock Market is rising 0.3% to $12,502.20, after two successive sessions in a row of gains, on what at the moment seems, a somewhat positive trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $3.59, 53.49% under its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 11.6% for the current quarter and 4.6% for the next. The company’s growth estimates for the current quarter is 25% and a drop 10% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Top and Bottom Yearly Value

Catalyst Pharmaceuticals’s stock is valued at $3.44 at 15:10 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $3.32 and below its 200-day moving average of $3.82.

LEAVE A REPLY

Please enter your comment!
Please enter your name here